Answer
Ezetrol (ezetimibe) with fenofibrate carries a possible risk of gallstones (cholelithiasis) and gallbladder disease; suspected gallstones require gallbladder investigations and discontinuation of this therapy.
Sources for this answer
- Ezetrol 10mg TabletsOrganon Pharma (UK) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 26Document updated
Sources checked